Rare brain issues linked to weight loss drugs

A new study warns that weight loss medications from the GLP-1 receptor agonist class, such as semaglutide and tirzepatide, may cause a rare and serious brain condition called Wernicke's encephalopathy due to severe vitamin B1 deficiency. The study documented 15 cases of this condition among users of these drugs, which suppress appetite and can cause nausea and vomiting, increasing the risk of vitamin B1 deficiency. This vitamin plays an important role in brain functions, and its deficiency can lead to confusion, difficulty walking, balance problems, and potential permanent damage or death if left untreated. Researchers emphasized that this condition is rare and that the findings do not directly prove that the medications cause it. However, they advise close nutritional monitoring and seeking medical attention if persistent symptoms occur. They also stress the need for further studies to better understand the relationship.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل